Application 201743
- Type
- NDA
- Sponsor
- SANDOZ
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ARGATROBAN IN DEXTROSE | ARGATROBAN | SOLUTION;INTRAVENOUS | 125MG/125ML (1MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N201743-001 | ARGATROBAN IN DEXTROSE | ARGATROBAN | 125MG/125ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2011-05-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | N201743-001 | ARGATROBAN IN DEXTROSE | 125MG/125ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2011-05-09 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N201743-001 | ARGATROBAN IN DEXTROSE | 125MG/125ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2011-05-09 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N201743-001 | ARGATROBAN IN DEXTROSE | 125MG/125ML (1MG/ML) | SOLUTION / INTRAVENOUS | 2011-05-09 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Argatroban | ARGATROBAN | Par Health USA, LLC | 1a67a87d-59cb-414c-a11e-ab8f0a9bb778 | 2026-08-20 | Warnings, Adverse reactions | ARGATROBAN |
| Argatroban | ARGATROBAN | Par Health USA, LLC | d4e5238f-2378-424e-bda2-f1a2cf874041 | 2026-08-19 | Warnings, Adverse reactions | ARGATROBAN |
| Argatroban | ARGATROBAN | Sagent Pharmaceuticals | 629aee90-3bf3-4947-a978-21cbba2e1c41 | 2026-07-29 | Warnings, Adverse reactions | ARGATROBAN |
| Argatroban | ARGATROBAN | Mullan Pharmaceutical Inc. | 546484ed-afab-b47b-e063-6394a90aa52d | 2026-06-16 | Warnings, Adverse reactions | ARGATROBAN |
| Argatroban | ARGATROBAN | Mullan Pharmaceutical Inc. | 50e21062-f021-40f2-ad11-896f46378a15 | 2026-06-15 | Warnings, Adverse reactions | ARGATROBAN |
| Argatroban | ARGATROBAN | Gland Pharma Limited | 270dbb59-e080-4a64-91d9-a68bed4bd2e5 | 2026-06-09 | Warnings, Adverse reactions | ARGATROBAN |
| ARGATROBAN | ARGATROBAN | Accord Healthcare Inc. | 46cdf9e6-839c-49c8-9ee1-c30cfdd9368d | 2026-05-21 | Warnings, Adverse reactions | ARGATROBAN |
| Argatroban | ARGATROBAN | Hikma Pharmaceuticals USA Inc. | 0cdf3f67-5bf3-4d58-b330-03febdc652bf | 2026-05-03 | Warnings, Adverse reactions | ARGATROBAN |
| ARGATROBAN | ARGATROBAN | Caplin Steriles Limited | b5143563-ff45-433a-a9e2-f8b8340db1f5 | 2026-04-17 | Warnings, Adverse reactions | ARGATROBAN |
| Argatroban | ARGATROBAN | Gland Pharma Limited | e5ccb93c-f411-4e7e-824a-4a592b4947ec | 2026-03-17 | Warnings, Adverse reactions | ARGATROBAN |
| Argatroban | ARGATROBAN | Fresenius Kabi USA, LLC | dfa5d325-f609-4c9a-aaae-1a17df47da1e | 2025-09-03 | Warnings, Adverse reactions | ARGATROBAN |
| Argatroban | ARGATROBAN | Mylan Institutional LLC | b0dedf95-8395-46bf-b94a-dcf2dd085942 | 2025-08-15 | Warnings, Adverse reactions | ARGATROBAN |
| Argatroban | ARGATROBAN | Hikma Pharmaceuticals USA Inc. | 41f56fe7-4824-4032-aa73-cfb4f8db2252 | 2024-04-11 | Warnings, Adverse reactions | ARGATROBAN |
| Argatroban | ARGATROBAN | Hikma Pharmaceuticals USA Inc. | 79eec27d-ac63-4996-8b1a-c2cd52ad2b2c | 2024-04-11 | Warnings, Adverse reactions | ARGATROBAN |
| Argatroban | ARGATROBAN | Eugia US LLC | d9b975bd-e3f4-466e-96ca-7bef7899506d | 2023-08-03 | Warnings, Adverse reactions | ARGATROBAN |
| Argatroban | ARGATROBAN | Amneal Pharmaceuticals LLC | dedef330-555a-46b7-b1d6-0838b4cd9651 | 2019-05-23 | Warnings, Adverse reactions | ARGATROBAN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.